AnPac Bio-Medical Science...

NASDAQ: ANPC · Real-Time Price · USD
4.30
-0.14 (-3.15%)
At close: May 19, 2023, 9:59 PM

AnPac Bio-Medical Science Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
12.04M 15.91M 13.94M 17.77M 17.99M 25.38M 25.71M 21.64M
Cost of Revenue
3.71M 3.4M 3.99M 5.7M 5.73M 8.84M 8.99M 8M
Gross Profit
8.34M 12.51M 9.95M 12.07M 12.25M 16.55M 16.73M 13.64M
Operating Income
-104.81M -104.92M -110.55M -101.47M -112.1M -95.75M -85.96M -93.08M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-105.73M -105.47M -114.48M -106.99M -121.27M -100.19M -82.27M -67.61M
Net Income
-101.32M -100.15M -110.5M -104.59M -118.72M -98.48M -81.45M -67.07M
Selling & General & Admin
82.94M 78.45M 78.87M 92.23M 102.1M 99.47M 91.45M 69.14M
Research & Development
9.53M 12.26M 14.92M 15.26M 16.2M 12.22M 9.76M 9.08M
Other Expenses
n/a n/a n/a n/a n/a 142K 191K n/a
Operating Expenses
92.47M 90.71M 93.78M 107.48M 118.3M 111.69M 101.25M 78.08M
Interest Expense
373K 411K 2.23M 3.73M 4.26M 4.7M 2.85M 2.27M
Selling & Marketing Expenses
12.15M 12.95M 15.96M 20.49M 21.42M 26.59M 25.81M 21.41M
Cost & Expenses
96.18M 94.12M 97.78M 113.18M 124.03M 120.52M 110.24M 86.08M
Income Tax Expense
-4.4M -5.33M -3.27M -1.25M -1.18M -133K -97K -162K
Shares Outstanding (Basic)
1.91M 1.45M 865.08K 865.08K 597.9K 11.96M 597.9K 597.9K
Shares Outstanding (Diluted)
1.91M 1.45M 865.08K 865.08K 597.9K 11.96M 597.9K 597.9K
EPS (Basic)
-87.27 -122.44 -111.04 -118.68 -150.01 -116.15 -136.22 -112.17
EPS (Diluted)
-87.27 -122.44 -111.04 -118.68 -150.01 -116.15 -136.22 -112.17
EBITDA
-83.9M -83.3M -90.34M -102.09M -115.62M -93.91M -78.7M -64.21M
EBIT
-105.36M -105.06M -112.25M -103.26M -117.01M -95.49M -79.43M -65.34M
Depreciation & Amortization
20.91M 21.63M 20.22M -625K -3.52M -4.3M 1.11M 1.15M